Published on GHDx (https://ghdx.healthdata.org)

Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden

General Info

Geography 
Afghanistan (AFG)
Angola (AGO)
Armenia (ARM)
Azerbaijan (AZE)
Bangladesh (BGD)
Benin (BEN)
Bhutan (BTN)
Bolivia (BOL)
Burkina Faso (BFA)
Burundi (BDI)
Cambodia (KHM)
Cameroon (CMR)
Central African Republic (CAF)
Chad (TCD)
Comoros (COM)
Congo (COG)
Cuba (CUB)
Côte d'Ivoire (CIV)
Democratic Republic of the Congo (COD)
Djibouti (DJI)
Eritrea (ERI)
Ethiopia (ETH)
Gambia (GMB)
Georgia (GEO)
Ghana (GHA)
Guinea (GIN)
Guinea-Bissau (GNB)
Guyana (GUY)
Haiti (HTI)
Honduras (HND)
India (IND)
Indonesia (IDN)
Kenya (KEN)
Kiribati (KIR)
Kyrgyzstan (KGZ)
Lao People's Democratic Republic (LAO)
Lesotho (LSO)
Liberia (LBR)
Madagascar (MDG)
Malawi (MWI)
Mali (MLI)
Mauritania (MRT)
Mongolia (MNG)
Mozambique (MOZ)
Myanmar (MMR)
Nepal (NPL)
Nicaragua (NIC)
Niger (NER)
Nigeria (NGA)
Pakistan (PAK)
Papua New Guinea (PNG)
Republic of Korea (KOR)
Republic of Moldova (MDA)
Rwanda (RWA)
Sao Tome and Principe (STP)
Senegal (SEN)
Sierra Leone (SLE)
Solomon Islands (SLB)
Somalia (SOM)
Sri Lanka (LKA)
Sudan (SDN)
Tajikistan (TJK)
Timor-Leste (TLS)
Togo (TGO)
Uganda (UGA)
Ukraine (UKR)
United Republic of Tanzania (TZA)
Uzbekistan (UZB)
Viet Nam (VNM)
Yemen (YEM)
Zambia (ZMB)
Zimbabwe (ZWE)
View all
Time period covered 
January, 2009 - December, 2010
Data type
Scientific literature
Keywords 
HPV, HPV vaccines, Preventive interventions, Rotavirus

Citation

Authors 
Kim SY, Sweet S, Chang J, Goldie SJ
Journal 
BMC Infect Dis
Pages 
1-17
Publication year 
2011
Suggested citation 
Kim SY, Sweet S, Chang J, Goldie SJ. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden. BMC Infect Dis. 2011; 11(174): 1-17.
Source URL:https://ghdx.healthdata.org/record/comparative-evaluation-potential-impact-rotavirus-versus-hpv-vaccination-gavi-eligible